相似文献
1
Antibody manufacture in transgenic animals and comparisons with other systems.
Curr Opin Biotechnol. 2002 Dec;13(6):625-9. doi: 10.1016/s0958-1669(02)00362-2.
2
Production of recombinant antibodies in the milk of transgenic animals.
Res Immunol. 1998 Jul-Aug;149(6):609-10. doi: 10.1016/s0923-2494(98)80014-x.
3
Generation and production of engineered antibodies.
Mol Biotechnol. 2004 Jan;26(1):39-60. doi: 10.1385/MB:26:1:39.
4
Production of monoclonal antibodies in plants for cancer immunotherapy.
Biomed Res Int. 2015;2015:306164. doi: 10.1155/2015/306164. Epub 2015 Oct 15.
5
Transgenic milk as a method for the production of recombinant antibodies.
J Immunol Methods. 1999 Dec 10;231(1-2):147-57. doi: 10.1016/s0022-1759(99)00151-9.
6
Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen.
Biotechnol Appl Biochem. 2003 Dec;38(Pt 3):223-30. doi: 10.1042/BA20030028.
7
Production systems for recombinant antibodies.
Front Biosci. 2008 May 1;13:4576-94. doi: 10.2741/3024.
8
An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification.
Vaccine. 2005 Mar 7;23(15):1833-7. doi: 10.1016/j.vaccine.2004.11.023.
9
Adenoviral vector mediates high expression levels of human growth hormone in the milk of mice and goats.
J Biotechnol. 2004 Oct 19;114(1-2):89-97. doi: 10.1016/j.jbiotec.2004.06.009.
10
Monoclonal antibody manufacturing in transgenic plants--myths and realities.
Curr Opin Biotechnol. 2002 Dec;13(6):630-5. doi: 10.1016/s0958-1669(02)00351-8.
引用本文的文献
1
Structure of the Fab fragment of a humanized 5E5 antibody to a cancer-specific Tn-MUC1 epitope.
Acta Crystallogr D Struct Biol. 2025 May 1;81(Pt 5):223-233. doi: 10.1107/S2059798325002554. Epub 2025 Apr 13.
2
Genetically modified chickens as bioreactors for protein-based drugs.
Front Genome Ed. 2025 Jan 7;6:1522837. doi: 10.3389/fgeed.2024.1522837. eCollection 2024.
3
Development of a Mucus Gland Bioreactor in Loach .
Int J Mol Sci. 2021 Jan 12;22(2):687. doi: 10.3390/ijms22020687.
4
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle.
Sci Rep. 2018 Sep 4;8(1):13208. doi: 10.1038/s41598-018-31417-2.
5
The transgenic animal platform for biopharmaceutical production.
Transgenic Res. 2016 Jun;25(3):329-43. doi: 10.1007/s11248-016-9933-9. Epub 2016 Jan 28.
6
Expression of recombinant vaccines and antibodies in plants.
Monoclon Antib Immunodiagn Immunother. 2014 Jun;33(3):192-8. doi: 10.1089/mab.2014.0049.
7
Use of transgenic animals in biotechnology: prospects and problems.
Acta Naturae. 2013 Jan;5(1):33-46.
8
Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin.
Reprod Biol Endocrinol. 2012 Jan 27;10:6. doi: 10.1186/1477-7827-10-6.
9
The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.
Expert Opin Drug Deliv. 2010 Apr;7(4):461-78. doi: 10.1517/17425240903579963.
10
Cell engineering and molecular pharming for biopharmaceuticals.
Open Med Chem J. 2008 May 14;2:49-61. doi: 10.2174/1874104500802010049.
本文引用的文献
1
Toward a new cash cow.
Nat Biotechnol. 2002 Sep;20(9):881-2. doi: 10.1038/nbt0902-881.
2
Position-independent and tissue-specific expression of porcine whey acidic protein gene from a bacterial artificial chromosome in transgenic mice.
Mol Reprod Dev. 2002 Oct;63(2):161-7. doi: 10.1002/mrd.90007.
3
Cloned transchromosomic calves producing human immunoglobulin.
Nat Biotechnol. 2002 Sep;20(9):889-94. doi: 10.1038/nbt727. Epub 2002 Aug 12.
4
Uncorking the biomanufacturing bottleneck.
Nat Biotechnol. 2002 Aug;20(8):777-9. doi: 10.1038/nbt0802-777.
5
Neutralizing antibodies against HIV -- back in the major leagues?
Curr Opin Immunol. 2002 Aug;14(4):495-502. doi: 10.1016/s0952-7915(02)00362-x.
6
Human anti-rhesus D IgG1 antibody produced in transgenic plants.
Transgenic Res. 2002 Apr;11(2):115-22. doi: 10.1023/a:1015226418688.
7
Therapeutic antibodies: magic bullets hit the target.
Nature. 2002 Jun 6;417(6889):584-6. doi: 10.1038/417584a.
8
Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities.
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6883-8. doi: 10.1073/pnas.102179399.
9
Plantibodies: applications, advantages and bottlenecks.
Curr Opin Biotechnol. 2002 Apr;13(2):161-6. doi: 10.1016/s0958-1669(02)00303-8.
10
Recombinant protein expression for therapeutic applications.
Curr Opin Biotechnol. 2002 Apr;13(2):117-23. doi: 10.1016/s0958-1669(02)00300-2.
Zotero 插件